BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36064991)

  • 1. Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes.
    Ronsini C; Solazzo MC; Bizzarri N; Ambrosio D; La Verde M; Torella M; Carotenuto RM; Cobellis L; Colacurci N; De Franciscis P
    Ann Surg Oncol; 2022 Dec; 29(13):8346-8358. PubMed ID: 36064991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: Can One Still Effectively Become a Mother? A Systematic Review of Fertility Outcomes.
    Ronsini C; Solazzo MC; Molitierno R; De Franciscis P; Pasanisi F; Cobellis L; Colacurci N
    Ann Surg Oncol; 2023 Sep; 30(9):5587-5596. PubMed ID: 37261562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparo-assisted vaginal radical hysterectomy as a safe option for Minimal Invasive Surgery in early stage cervical cancer: A systematic review and meta-analysis.
    Ronsini C; Köhler C; De Franciscis P; La Verde M; Mosca L; Solazzo MC; Colacurci N
    Gynecol Oncol; 2022 Jul; 166(1):188-195. PubMed ID: 35513934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Burbano J; Heredia F; Sanabria D; Ardila EG; Viveros-Carreño D; Rodriguez J
    Int J Gynecol Cancer; 2021 Mar; 31(3):387-398. PubMed ID: 33649006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gwacham NI; McKenzie ND; Fitzgerald ER; Ahmad S; Holloway RW
    Gynecol Oncol; 2021 Sep; 162(3):809-815. PubMed ID: 34130862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparo-assisted vaginal radical hysterectomy as a safe option for minimal invasive surgery in early stage cervical cancer: A systematic review and meta-analysis.
    Ronsini C; Köhler C; de Franciscis P; La Verde M; Mosca L; Solazzo MC; Colacurci N
    Gynecol Oncol; 2022 Sep; ():. PubMed ID: 36150915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.
    Kuznicki ML; Chambers LM; Morton M; Son J; Horowitz M; Crean-Tate KK; Hackett L; Rose PG
    J Minim Invasive Gynecol; 2021 Mar; 28(3):513-526.e1. PubMed ID: 33223017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Viveros-Carreño D; Rodriguez J; Rendon Pereira GJ; Slama J; Halaska MJ; Robova H; Pareja R
    Int J Gynecol Cancer; 2022 Apr; 32(4):486-493. PubMed ID: 35210296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    van Kol KGG; Vergeldt TFM; Bekkers RLM
    Gynecol Oncol; 2019 Dec; 155(3):515-521. PubMed ID: 31606284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oncological Implication of Sentinel Lymph Node in Early Cervical Cancer: A Meta-Analysis of Oncological Outcomes and Type of Recurrences.
    Ronsini C; De Franciscis P; Carotenuto RM; Pasanisi F; Cobellis L; Colacurci N
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363496
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Noll F; Palacios Torres AT; Pecci P; Lucchini SM; Heredia F
    Int J Gynecol Cancer; 2021 Mar; 31(3):379-386. PubMed ID: 33649005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.
    Rendón GJ; Lopez Blanco A; Aragona A; Saadi JM; Di Guilmi J; Arab Eblen C; Heredia Muñoz F; Pareja R
    Int J Gynecol Cancer; 2021 Mar; 31(3):462-467. PubMed ID: 33199429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review.
    Buda A; Borghese M; Puppo A; Perotto S; Novelli A; Borghi C; Olearo E; Tripodi E; Surace A; Bar E; Scambia G; Fanfani F
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
    Tsubamoto H; Kanazawa R; Inoue K; Ito Y; Komori S; Maeda H; Hirota S
    Int J Gynecol Cancer; 2012 Jul; 22(6):1057-62. PubMed ID: 22683943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review.
    Di Donato V; Caruso G; Sassu CM; Santangelo G; Bogani G; Plotti F; Sorbi F; Perniola G; Palaia I; Terrin G; Angioli R; Benedetti Panici P; Muzii L
    J Gynecol Oncol; 2021 Nov; 32(6):e83. PubMed ID: 34431254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review.
    Nezhat C; Roman RA; Rambhatla A; Nezhat F
    Fertil Steril; 2020 Apr; 113(4):685-703. PubMed ID: 32228873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2cm or larger: A literature review and analysis of oncological and obstetrical outcomes.
    Pareja R; Rendón GJ; Vasquez M; Echeverri L; Sanz-Lomana CM; Ramirez PT
    Gynecol Oncol; 2015 Jun; 137(3):574-80. PubMed ID: 25827293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment.
    Kasius JC; van der Velden J; Denswil NP; Tromp JM; Mom CH
    Best Pract Res Clin Obstet Gynaecol; 2021 Sep; 75():82-100. PubMed ID: 33752979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.